Immunogenicity of 10 and 20 μg hepatitis B vaccine in a two-dose schedule
Authors:
- Najib Ul-HaqNUNajib Ul-Haq
- Syed S. HasnainSHSyed S. Hasnain
- Muhammad UmarMUMuhammad Umar
- Zaigham AbbasZAZaigham Abbas
- Carmen Valenzuela-SilvaCVCarmen Valenzuela-Silva
- Pedro Lopez-SauraPLPedro Lopez-Saura
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Economic Evaluation of a 2-Dose Hepatitis B Vaccination Regimen for AdolescentsPediatrics, 2001
- Moderate Immunization Coverage Levels in East Delhi: Implications for Disease Control Programmes and Introduction of New VaccinesJournal of Tropical Pediatrics, 2001
- A Randomized Trial of Alternative Two- and Three-Dose Hepatitis B Vaccination Regimens in Adolescents: Antibody Responses, Safety, and Immunologic MemoryPediatrics, 2001
- Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccinesClinical Therapeutics, 2001
- Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experienceVaccine, 2001
- A comparison of two commercial recombinant vaccines for hepatitis B in adolescentsVaccine, 2000
- Large-scale production of recombinant hepatitis B surface antigen from Pichia pastorisJournal of Biotechnology, 2000
- Summary of safety and efficacy data on a yeast-derived hepatitis B vaccineThe American Journal of Medicine, 1989
- Overview of clinical studies with hepatitis B vaccine made by recombinant DNAJournal of Infection, 1986
- Hepatitis B VaccineNew England Journal of Medicine, 1980